2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Ischemix, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of CMX-2043 for Protection of the Heart and Kidneys in Subjects Undergoing Coronary Angiography CMX-2043, Placebo comparator - Non STEMI, Unstable Angina | Phase 2 | Completed | Ischemix, LLC | 361 | 2014-06-01 | 2016-02-23 |
| Safety and Efficacy of CMX-2043 in Subjects Undergoing Coronary Reperfusion Therapy CMX-2043, Placebo control - Stable Coronary Artery Disease, Percutaneous Coronary Intervention | Phase 2 | Completed | Ischemix, LLC | 142 | 2010-02-01 | 2011-06-20 |
Angina, Unstable (1) · Non-ST Elevated Myocardial Infarction (1)
alpha-N-(1,2-dithiolane-3-pentanoyl)glutamylalanine (2)
India (1) · United States (1)
Alan S Lader, PhD (1) · Alan S. Lader, Ph.D. (1)